First Needle-Free Patch RSV Vaccine Being Created

Atlanta, Bioscience, CDC, Centers for Disease Control and Prevention, COVID-19, Department of Defense, DoD, DS2, HD-MAP RSV, Health Articles, high-density microarray patch, James Goodson, Micron Biomedical, Natasha Hobley, National Institutes of Health, National Vaccine Information Center, NIH, NVIC, Orlance, Seattle, The Vaccine Reaction, Vaccine Alliance Gavi, Vaccine Research Center, Vaccines, Vaxxas /

The U.S. National Institutes of Health (NIH) has granted the Biotech company Vaxxas Pty. Ltd. of Australia a worldwide license to a respiratory syncytial virus (RSV) antigen known as DS2. The license will allow for the firm to create the first needle-free and room-temperature stable RSV vaccine using a novel and “cutting edge” high-density microarray […]

First Needle-Free Patch RSV Vaccine Being Created Read More »